DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 48 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $534,000 | -27.3% | 35,000 | -41.7% | 0.01% | -28.6% |
Q2 2018 | $735,000 | -7.7% | 60,000 | -28.0% | 0.01% | -22.2% |
Q1 2018 | $796,000 | -41.2% | 83,300 | -44.4% | 0.01% | -40.0% |
Q4 2017 | $1,354,000 | +39.9% | 149,900 | -10.9% | 0.02% | +36.4% |
Q3 2017 | $968,000 | +227.0% | 168,300 | +80.4% | 0.01% | +175.0% |
Q2 2017 | $296,000 | -6.6% | 93,300 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $317,000 | +17.8% | 93,300 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $269,000 | -51.0% | 93,300 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $549,000 | +92.0% | 93,300 | +75.0% | 0.01% | +60.0% |
Q1 2016 | $286,000 | -61.9% | 53,300 | -15.8% | 0.01% | -64.3% |
Q4 2015 | $751,000 | +44.4% | 63,300 | 0.0% | 0.01% | +27.3% |
Q3 2015 | $520,000 | -17.2% | 63,300 | +40.7% | 0.01% | -8.3% |
Q2 2015 | $628,000 | -41.9% | 45,000 | 0.0% | 0.01% | -45.5% |
Q1 2015 | $1,081,000 | +45.9% | 45,000 | 0.0% | 0.02% | +29.4% |
Q4 2014 | $741,000 | – | 45,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |